Concepedia

Jing Peng

JP

6

Publications

136

Citations

6

H-Index

2006

Active since

Affiliations

Novartis (United States)(Current)

Jing Peng is an author at Novartis (United States) specializing in cell biology, medicine, and cancer research.

Top concepts

MedicineCell BiologyPathologyImmunologyTumor BiologyCancer ResearchTumor MicroenvironmentDiabetesOncologyPhysiology

Publications per year

2006–2021

6

Publications

6

Fucoxanthin regulates Nrf2 signaling to decrease oxidative stress and improves renal fibrosis depending on Sirt1 in HG-induced GMCs and STZ-induced diabetic rats

Guanyu Yang, Qingde Li, Jing Peng et al. · European Journal of Pharmacology · 2021 · 32 citations

Inflammation, Redox Signaling, Medicine +12

Recombinant Interleukin-2 Significantly Augments Activity of Rituximab in Human Tumor Xenograft Models of B-cell Non-Hodgkin Lymphoma

Daniel E. Lopes de Menezes, Kimberly Denis-Mize, Yan Tang et al. · Journal of Immunotherapy · 2006 · 28 citations

Rituximab Single Agents, Lymphoid Neoplasia, Rituximab F +15

Expressions of miR-181a and miR-20a in RPMI8226 cell line and their potential as biomarkers for multiple myeloma

Jing Peng, Asmitananda Thakur, Shuo Zhang et al. · Tumor Biology · 2015 · 26 citations

Expression of cancer cell-derived IgG and extra domain A-containing fibronectin in salivary adenoid cystic carcinoma

Wanqi Lv, Jing Peng, Haicheng Wang et al. · Archives of Oral Biology · 2017 · 17 citations

Tumor Biology, Medicine, Cancer Cell-derived Igg +7

LukS‐PV induces apoptosis in acute myeloid leukemia cells mediated by C5a receptor

Peng Zhang, Wenwei Yu, Jing Peng et al. · Cancer Medicine · 2019 · 17 citations · Full text

Rows per page

1–5 of 6